Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
2 clusters · 3 sources · 30 days · First seen · Last updated
Corporate executive stock liquidations
Overview
Reports indicate a series of significant stock liquidations by corporate executives across various industries. These transactions are frequently conducted under pre-arranged Rule 10b5-1 trading plans.
In late August, executives at Xeris Biopharma Holdings, Inc., including the CFO, Chief Legal Officer, and COO, sold a combined total of over $300,000 in stock. Despite these sales, the executives maintained substantial direct ownership in the company.
By late September, the scale of executive stock sales expanded to include multi-million dollar transactions. Notable liquidations included Marc Boroditsky of Nebius Group N.V., who sold approximately $1.5 million in shares, and Xiaodong Wang of BeOne Medicines Ltd., who sold over $11.3 million in shares, representing a 50% decrease in his position. Other reported sales involved executives from Cerebras Systems Inc., EOG Resources, Inc., and Abeona Therapeutics Inc.
Entities
Beth Hecht · BeOne Medicines Ltd. · Nebius Group N.V. · Abeona Therapeutics Inc. · EOG Resources, Inc.
Timeline
-
[BUSINESS] 2 sourcesCorporate executives execute multi-million dollar stock sales
Multiple corporate executives from companies including Nebius Group, Cerebras Systems, EOG Resources, Abeona Therapeutics, and BeOne Medicines have reported significant stock sales via SEC filings.
-
[BUSINESS] 2 sourcesXeris Biopharma executives sell over $300,000 in stock
Top executives at Xeris Biopharma, including the CFO, COO, and Chief Legal Officer, sold over $300,000 in stock via automated trading plans on September 1.
Sources
ad-hoc-news.de · stocknews.com · theascent.com